Skip to main content
Caplight Logo









Humanase Co., Ltd.

Humanase Co., Ltd.

Private
South KoreaHealthcare & Life Scienceshttps://www.humanase.co.kr/

Last Round

Grant

May 12, 2025

Total Funding Raised

$2.84M

Company Overview

Humanase Co., Ltd. is a drug discovery company that develops biomimetic organ-on-a-chip technology to create in-vitro platforms for new drug development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

organ-on-a-chipOoCanimal testing alternativebiomimetic chippreclinical testingdrug discoverymicrofluidics3D cell culturetoxicity testingin-vitro modelCRO servicesdisease modelingmulti-organ chipbody-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Humanase Co., Ltd. Comparables

Compare Humanase Co., Ltd. with similar companies based on industry and business-model similarity.

Humanase Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AlveoliX AG
85%
MEPSGEN
84%
Qureator
83%

Humanase Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 12, 2025
GrantApr 1, 2024
GrantMay 1, 2023
AngelMay 1, 2023
GrantOct 1, 2022
Seed
Sep 1, 2022

Humanase Co., Ltd. Investors

Notable investors and investment history

Humanase Co., Ltd. investors
InvestorRounds
Ministry of Science and ICT of South KoreaGrant
Gachon UniversityGrant
BSK InvestmentSeed, Grant
FirstgateSeed
Government of South KoreaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors grew 124% MoM, reaching 3K.

  • May 12, 2025

    $2.38M grant from the Ministry of Science and ICT of South Korea.

Humanase Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Humanase Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Humanase Co., Ltd.'s valuation, stock price, and market status.

Is Humanase Co., Ltd. a public or private company?

Humanase Co., Ltd. is a private company.

What is the current stock price of Humanase Co., Ltd.?

Humanase Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Humanase Co., Ltd. worth (valuation)?

Valuation information for Humanase Co., Ltd. is not publicly available.

Can I buy Humanase Co., Ltd. stock?

Humanase Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Humanase Co., Ltd.'s last funding round?

Humanase Co., Ltd.'s most recent funding round was Grant on May 12, 2025.

Who are the main investors in Humanase Co., Ltd.?

Key investors in Humanase Co., Ltd. include Ministry of Science and ICT of South Korea, Gachon University, BSK Investment, Firstgate, Government of South Korea.

Will Humanase Co., Ltd. IPO soon?

No public IPO plans have been announced for Humanase Co., Ltd..

How can I track Humanase Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Humanase Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSouth Korea
Employee Range3
Year Founded2021
Last FundingMay 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?